Likewise, non-genetic HF (HFrEF/HFpEF) by similar mechanisms of action to change cMyBP-C interactions as in HCM/DCM for alleviating dysfunction of hypo- or hyper-contractility could provide effective new intervening therapies. This evidence concerns the gene MYBPC3 and hydrops fetalis.